Xtant Medical Holdings (XTNT) Asset Writedowns and Impairment (2014 - 2025)
Xtant Medical Holdings' (XTNT) quarterly Asset Writedowns and Impairment came in at $828000.0 in Q3 2025, up 169.71% year-over-year from $307000.0 in Q3 2024, and up 1723.53% quarter-over-quarter from -$51000.0 in Q2 2025.
Powered by 
Analysis
Xtant Medical Holdings (XTNT) Asset Writedowns and Impairment (2014 - 2025) Analysis & Trends
Xtant Medical Holdings (XTNT) has reported Asset Writedowns and Impairment for 9 consecutive years, with $828000.0 the latest figure, recorded in Q3 2025.
- On a quarterly basis, Asset Writedowns and Impairment rose 169.71% year-over-year to $828000.0 in Q3 2025; TTM through Sep 2025 was $1.1 million, a 69.42% increase from a year earlier, with the FY2024 full-year figure at $485000.0, up 35.85% from the prior year.
- Asset Writedowns and Impairment was $828000.0 for Q3 2025 at Xtant Medical Holdings, up from -$51000.0 in the prior quarter.
- Over five years, Asset Writedowns and Impairment peaked at $828000.0 in Q3 2025 and troughed at -$210000.0 in Q4 2024.
- A 5-year average of $212789.5 and a median of $153000.0 in 2023 frame the typical range for Asset Writedowns and Impairment.
- Across the five-year window, Asset Writedowns and Impairment surged 2327.27% in 2021 and plunged 412.2% in 2024, its largest moves.
- Over 5 years, Asset Writedowns and Impairment stood at $267000.0 in 2021, then retreated by 8.61% to $244000.0 in 2022, then sank by 116.8% to -$41000.0 in 2023, then sank by 412.2% to -$210000.0 in 2024, then surged by 494.29% to $828000.0 in 2025.
- The last three Asset Writedowns and Impairment figures came in at $828000.0 (Q3 2025), -$51000.0 (Q2 2025), and $541000.0 (Q1 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | Xtant Medical Holdings | 47.61 Mn | 30.01 Mn | 17.75 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 828,000.00 |
| Jun 30, 2025 | -51,000.00 |
| Mar 31, 2025 | 541,000.00 |
| Dec 31, 2024 | -210,000.00 |
| Sep 30, 2024 | 307,000.00 |
| Jun 30, 2024 | 129,000.00 |
| Mar 31, 2024 | 259,000.00 |
| Dec 31, 2023 | -41,000.00 |
| Sep 30, 2023 | 155,000.00 |
| Jun 30, 2023 | 153,000.00 |
| Mar 31, 2023 | 90,000.00 |
| Dec 31, 2022 | 244,000.00 |
| Sep 30, 2022 | 743,000.00 |
| Jun 30, 2022 | 49,000.00 |
| Mar 31, 2022 | 318,000.00 |
| Dec 31, 2021 | 267,000.00 |
| Sep 30, 2021 | 118,000.00 |
| Jun 30, 2021 | 81,000.00 |
| Mar 31, 2021 | 63,000.00 |
| Dec 31, 2020 | 11,000.00 |